SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-019582
Filing Date
2020-02-13
Accepted
2020-02-13 06:02:06
Documents
20
Period of Report
2020-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207823-1_8k.htm   iXBRL 8-K 32121
2 EXHIBIT 1.1 tm207823d1_ex1-1.htm EX-1.1 227602
3 EXHIBIT 5.1 tm207823d1_ex5-1.htm EX-5.1 33694
4 EXHIBIT 99.1 tm207823d1_ex99-1.htm EX-99.1 18528
5 EXHIBIT 99.2 tm207823d1_ex99-2.htm EX-99.2 270681
9 GRAPHIC tm207823d1_ex5-1img001.jpg GRAPHIC 12138
10 GRAPHIC tm207823d1_ex5-1img002.jpg GRAPHIC 15209
11 GRAPHIC tm207823d1_ex99-1img001.jpg GRAPHIC 127175
12 GRAPHIC tm207823d1_ex99-1img002.jpg GRAPHIC 96865
  Complete submission text file 0001104659-20-019582.txt   1249648

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tbph-20200210.xsd EX-101.SCH 3192
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20200210_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20200210_pre.xml EX-101.PRE 22714
13 EXTRACTED XBRL INSTANCE DOCUMENT tm207823-1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 20606745
SIC: 2834 Pharmaceutical Preparations